TransMedics Group, Inc.

NASDAQ (USD): TransMedics Group, Inc. (TMDX)

Last Price

80.48

Today's Change

-7.88 (8.91%)

Day's Change

80.06 - 88.93

Trading Volume

2,261,494

Profile
TMDX

Exchange:  NASDAQ Global Market NASDAQ Global Market

Currency:  USD USD

Sector:  Healthcare - Healthcare Healthcare - Healthcare

Industry: 

CEO:  Dr. Waleed H. Hassanein M.D. Dr. Waleed H. Hassanein M.D.

Full Time Employees:  584 584

IPO Date:  2019-05-02 2019-05-02

CIK:  0001756262 0001756262

ISIN:  US89377M1099 US89377M1099

CUSIP:  89377M109 89377M109

Beta:  2.07 2.07

Last Dividend:  0.00 0.00

Dcf Diff:  84.04 84.04

Dcf:  -0.09 -0.09

Description

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for extracorporeal perfusion and preservation of donor hearts; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.

Address

200 Minuteman Road,
Andover, MA 01810, US

978 552 0900

http://www.transmedics.com

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment